Dosage form comprising parallel lamine
April 6, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3870790 Sustained release tablet formulations Novel sustained release tablet formulations Sustained release therapeutic compositions Method and composition for the preparation of controlled long-acting pharmaceuticals Carrier base material for prolonged release therapeutic compositions Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose Prolonged-action multiple-layer tablets Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose InventorsAssigneeApplicationNo. 07/034971 filed on 04/06/1987US Classes:424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/472Layered unitary dosage formsExaminersPrimary: Lusignan, Michael R.Attorney, Agent or FirmInternational ClassesA61K 9/20 (20060101)A61K 9/24 (20060101) AbstractA bilaminated dosage form is disclosed comprising at least 30 weight percent cellulose ether, a first lamina and a second lamina with each lamina comprising a different cellulose ether formulation, and a drug in at least one of the lamina. | |
